Target Name: CD44-DT
NCBI ID: G100507144
Other Name(s): LOC100507144 | Uncharacterized LOC100507144 | CD44 divergent transcript

CD44-DT: A Drug Target / Disease Biomarker

CD44-DT is a protein that is expressed in various tissues throughout the body, including the lungs, heart, kidneys, and gastrointestinal tract. It is a member of the CD44 family, which is known for its role in cell-cell adhesion and signaling. CD44-DT has been shown to be involved in a number of biological processes, including cell proliferation, migration, and survival.

One of the most promising aspects of CD44-DT is its potential as a drug target. Because it is involved in so many different processes in the body, it is a promising target for the development of new treatments for a wide range of diseases. For example, CD44-DT has been shown to be involved in cancer cell growth and metastasis, and may be a useful target for cancer treatments.

In addition to its potential as a drug target, CD44-DT has also been shown to be a useful biomarker for certain diseases. For example, it has been shown to be elevated in the blood of people with heart disease, and may be a useful indicator of the severity of this condition. It has also been shown to be elevated in the urine of people with kidney disease, and may be a useful indicator of the severity of this condition.

CD44-DT is also of interest to researchers because of its complex structure. The CD44 protein is composed of several hundred amino acids, and is known for its ability to form a tight, linear dimer in solution. This structure makes it difficult to study, and has presented a challenge for researchers trying to understand its function. However, recent studies have shown that CD44-DT is involved in a number of complex cellular processes, including cell-cell adhesion and signaling.

In conclusion, CD44-DT is a protein that is expressed in various tissues throughout the body, and is involved in a number of different biological processes. Its potential as a drug target and biomarker make it an attractive target for the development of new treatments for a wide range of diseases. Further research is needed to fully understand its function and potential as a drug.

Protein Name: CD44 Divergent Transcript

More Common Targets

CD46 | CD47 | CD48 | CD5 | CD52 | CD53 | CD55 | CD58 | CD59 | CD5L | CD6 | CD63 | CD68 | CD69 | CD7 | CD70 | CD72 | CD74 | CD79A | CD79B | CD8 | CD80 | CD81 | CD81-AS1 | CD82 | CD83 | CD84 | CD86 | CD8A | CD8B | CD8B2 | CD9 | CD93 | CD96 | CD99 | CD99L2 | CD99P1 | CDA | CDADC1 | CDAN1 | CDC123 | CDC14A | CDC14B | CDC14C | CDC16 | CDC20 | CDC20-DT | CDC20B | CDC20P1 | CDC23 | CDC25A | CDC25B | CDC25C | CDC26 | CDC27 | CDC27P2 | CDC34 | CDC37 | CDC37L1 | CDC37P1 | CDC40 | CDC42 | CDC42BPA | CDC42BPB | CDC42BPG | CDC42EP1 | CDC42EP2 | CDC42EP3 | CDC42EP4 | CDC42EP5 | CDC42SE1 | CDC42SE2 | CDC45 | CDC5L | CDC5L complex | CDC6 | CDC7 | CDC73 | CDCA2 | CDCA3 | CDCA4 | CDCA4P3 | CDCA5 | CDCA7 | CDCA7L | CDCA8 | CDCP1 | CDCP2 | CDH1 | CDH10 | CDH11 | CDH12 | CDH13 | CDH13-AS2 | CDH15 | CDH16 | CDH17 | CDH18 | CDH19 | CDH2